Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
NCT07500506 VLA15 Lyme Disease Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07500506 VLA15 Lyme Disease Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07500506 clinical trial report covering VLA15, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07499232 Risankizumab-RZAA Crohn Disease Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07499232 Risankizumab-RZAA Crohn Disease Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07499232 clinical trial report covering Risankizumab-RZAA, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07499544 Libevitug Hepatitis D, Chronic Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07499544 Libevitug Hepatitis D, Chronic Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07499544 clinical trial report covering Libevitug, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07502300 Tislelizumab Extensive stage Small Cell Lung Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07502300 Tislelizumab Extensive stage Small Cell Lung Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07502300 clinical trial report covering Tislelizumab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
CTR20260987 Semaglutide (Shanxi Jiayuan) Diabetes Mellitus, Type 2 Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
CTR20260987 Semaglutide (Shanxi Jiayuan) Diabetes Mellitus, Type 2 Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
CTR20260987 clinical trial report covering Semaglutide (Shanxi Jiayuan), Phase 3, endpoints, sponsor, geography, readout timing and development white space
Read →
NCT07503730 Tretinoin Acute Promyelocytic Leukemia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07503730 Tretinoin Acute Promyelocytic Leukemia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07503730 clinical trial report covering Tretinoin, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07503600 Melatonin Gram-Negative Bacterial Infections Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07503600 Melatonin Gram-Negative Bacterial Infections Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07503600 clinical trial report covering Melatonin, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07503587 HSK-44459 Progressive pulmonary fibrosis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07503587 HSK-44459 Progressive pulmonary fibrosis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07503587 clinical trial report covering HSK-44459, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07502820 Tamoxifen Citrate Drug adjuvant Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07502820 Tamoxifen Citrate Drug adjuvant Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07502820 clinical trial report covering Tamoxifen Citrate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07504458 Arsenic Trioxide Acute Promyelocytic Leukemia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07504458 Arsenic Trioxide Acute Promyelocytic Leukemia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07504458 clinical trial report covering Arsenic Trioxide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07503210 Zenagamtide Weight Loss Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07503210 Zenagamtide Weight Loss Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07503210 clinical trial report covering Zenagamtide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
CTR20261088 ZY-A002 Cough variant asthma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
CTR20261088 ZY-A002 Cough variant asthma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
CTR20261088 clinical trial report covering ZY-A002, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →